Published within
| Type |
Product title / description
|
Pub
|
Price |
Interactive Model
|
The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.
Published By Datamonitor
|
22 Mar 2013 |
$8000
|
Interactive Model
|
This interactive model includes 2010-20 sales forecasts for systemic lupus erythematosus in the US and five major EU markets (France, Germany, Italy, Spain, and the UK).
Published By Datamonitor
|
22 Aug 2011 |
$11400
|
Interactive Model
|
Coverage of disease-modifying drugs in the seven major rheumatoid arthritis markets, including indication-specific 10-year forecasts (using both sales and patient-based approaches), detailed brand profiling and an in-depth patient-based case study.
Published By Datamonitor
|
16 Dec 2010 |
$15200
|
Interactive Model
|
This interactive model includes 2010-20 patient-numbers and sales forecasts for traditional and biologic disease-modifying drugs in the seven major markets (the US, Japan, France, Germany, Italy, Spain and the UK).
Published By Datamonitor
|
08 Sep 2011 |
$11400
|
Interactive Model
|
Overview of the current and future psoriasis market, providing in-depth analysis of recent events in the market together with 10 year indication specific sales forecasts and profiles of key brands and pipeline products across the seven major markets.
Published By Datamonitor
|
16 Dec 2010 |
$15200
|
Interactive Model
|
Datamonitor uses a patient-based method to size psoriasis across the seven major markets over 2011–20, based on robust epidemiology and 2011 survey data. This report explores current and future market dynamics of biologic, oral and topical agents.
Published By Datamonitor
|
30 Nov 2011 |
$11400
|
Interactive Model
|
Analysis of the current and future inflammatory bowel disease market with indication-specific sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) for key marketed brands
Published By Datamonitor
|
05 Aug 2010 |
$15200
|
Interactive Model
|
Provides indication- and country-specific 10-year forecasts of key marketed, generic, and pipeline fibromyalgia drugs to 2018.
Published By Datamonitor
|
03 Jun 2009 |
$15200
|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.